ALCHEMIST A081801

Lung Cancer

ALCHEMIST: A081801 Integration of immunotherapy into adjuvant therapy for resected NSCLC: ALCHEMIST chemo-IO (ACCIO)

Key Team Members

Principal Investigator

James Leroy Wells III, MD

Research Coordinator

Selena Lollar

Accepting Patients

Enrollment Started: November 23, 2020

About the Trial

The purpose of this study is testing the addition of a type of drug called immunotherapy to the usual chemotherapy treatment for non-small cell lung cancer.

Get Primary Care

Photo of the Lexington Medical Center hospital campus

Lexington Medical Center

2720 Sunset Blvd.
West Columbia, SC 29169
Google Maps

Hospital Map

Emergency Room

Find More Locations